A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07266441 · RECRUITING
Trial details
- NCT number
- NCT07266441
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-08
- Primary completion
- 2027-06-14
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.